Abstract: A battery module includes: a plurality of battery cells; a module case configured to accommodate the plurality of battery cells; an electrode terminal provided outside the module case; and a fuse assembly provided to be attachable to or detachable from an outer side of the module case, and including a busbar having one end connected to the electrode terminal and the other end connected to an external cable and configured to break when an overcurrent occurs, and a fuse case configured to accommodate the busbar.

Abstract: The present invention relates to a viral complex comprising a viral vector capable of delivering shRNA that suppresses an expression of epidermal growth factor receptor (EGFR) to a cell and an anti-epithelial cell adhesion molecule (EpCAM) antibody conjugated to the viral vector, a pharmaceutical composition for preventing or treating cancer, comprising the viral complex, and a method for treating cancer, comprising administering the viral complex or the pharmaceutical composition to a subject in which a cancer disease has occurred and overexpressing EpCAM. The anti-EpCAM antibody-AAV2/shEGFR complex provided in the present invention significantly reduces the expression level of EGFR in tumor cells overexpressing EpCAM without inducing an immune response in vivo, thereby inducing death of tumor cells, and thus, it can be widely utilized in more effective and safe cancer treatment.

Abstract: An example method of an electronic device according to various embodiments of the present disclosure may include indicating that a first screen related to a first application operating in a background state is being displayed in an external electronic device, connected to the electronic device, based on data transmitted from the electronic device; and displaying an object floating on a second screen being displayed on the electronic device.

Abstract: A vehicle battery fire sensing apparatus and method includes a battery pack mounted to a vehicle structure and an electronic control unit. The battery pack includes a battery module including one or more battery cells, a battery management system configured to transmit a signal received from the battery module to the electronic control unit, and a battery pack case having a gas discharge portion configured to allow venting gas to be discharged therethrough. The vehicle battery fire sensing apparatus further includes a sensor provided at the vehicle structure, the sensor being configured to measure at least one of the temperature or pressure of the gas discharged from the gas discharge portion.

Abstract: The present invention relates to a method of treating a cancer including administering a pharmaceutical composition to an individual suspected to have the cancer excluding humans in a pharmaceutically effective amount, where the pharmaceutical composition comprises an agent capable of inhibiting expression of kinesin spindle protein (KSP) and a mitosis inhibitor.

Abstract: An example method of an electronic device according to various embodiments of the present disclosure may include indicating that a first screen related to a first application operating in a background state is being displayed in an external electronic device, connected to the electronic device, based on data transmitted from the electronic device; and displaying an object floating on a second screen being displayed on the electronic device.

Abstract: A method of an electronic device according to various embodiments of the present disclosure may comprise the operations of: indicating that a first screen related to a first application operating in a background state is being displayed in an external electronic device, connected to the electronic device, on the basis of data transmitted from the electronic device; and displaying an object floating on a second screen being displayed on the electronic device.

Abstract: What is discussed is an interconnection member including (a) a main cable made of a flexible flat cable (FFC) including copper wires, (b) terminal parts branched from the main cable and electrically connected to at least one of the copper wires of the main cable, (c) a connecting part formed on one-side end of the main cable, and electrically and mechanically connected to a PCB and (d) at least one temperature sensing part branched from the main cable, wherein the at least one temperature sensing part comprises a first extending part extending from the main cable while sharing at least one copper wire of the copper wires of the main cable and a ceramic thermistor disposed on an end of the first extending part while being electrically connected to the first extending part.

Abstract: Provided is an interconnection member including: (a) a main cable made of a flexible flat cable (FFC) including a plurality of copper wires; (b) a plurality of terminal parts branched from the main cable and electrically connected to at least one of the copper wires of the main cable, the plurality of terminal parts being connected to the bus bars to sense voltages of the battery cells; (c) a connecting part formed on one-side end of the main cable, and electrically and mechanically connected to the PCB; and (d) at least one temperature sensing part branched from the main cable, adjacent to the connecting part, while sharing at least one of the copper wires of the main cable.

Abstract: The present invention relates to a viral complex comprising a viral vector capable of delivering shRNA that suppresses an expression of epidermal growth factor receptor (EGFR) to a cell and an anti-epithelial cell adhesion molecule (EpCAM) antibody conjugated to the viral vector, a pharmaceutical composition for preventing or treating cancer, comprising the viral complex, and a method for treating cancer, comprising administering the viral complex or the pharmaceutical composition to a subject in which a cancer disease has occurred and overexpressing EpCAM. The anti-EpCAM antibody-AAV2/shEGFR complex provided in the present invention significantly reduces the expression level of EGFR in tumor cells overexpressing EpCAM without inducing an immune response in vivo, thereby inducing death of tumor cells, and thus, it can be widely utilized in more effective and safe cancer treatment.

Abstract: A method of an electronic device according to various embodiments of the present disclosure may comprise the operations of: indicating that a first screen related to a first application operating in a background state is being displayed in an external electronic device, connected to the electronic device, on the basis of data transmitted from the electronic device; and displaying an object floating on a second screen being displayed on the electronic device.

Abstract: The present invention relates to a composition for nucleus-independent, sustained inhibition of gene expression, comprising an mRNA fragment of T7 RNA polymerase, plasmid DNA for self-amplification of the T7 RNA polymerase, and a DNA fragment encoding a gene expression inhibitor; a transporter of the gene expression inhibitor comprising the composition; and a method of preparing the transporter. The composition of the present invention and the liposome transporter of the present invention comprising the composition can improve the expression of shRNA in the cytoplasm through self-amplification of nucleus-independent, sustained self-amplification of T7 RNA polymerase, and deliver them in a cancer tissue-specific manner. Therefore, the composition and the liposome transporter of the present invention can be utilized for use in treating chronic diseases that require reduced frequency of administration and long-term inhibition of gene expression.

Abstract: A battery cell assembly in which a plurality of electrically connected battery cells are arranged and first and second outer cover members each having a plate-type structure surrounding an outer surface of the battery cell assembly and coupled to each other by a fastening member in a state in which corners corresponding to each other are in contact with each other. Here, each of the first and second outer cover members includes at least one fastening groove having a slit shape, and the fastening grooves of the first and second outer cover members are perforated at positions corresponding to each other of corners contacting each other, and the first and second outer cover members are coupled to each other in such a manner that both side ends, which face each other, of the fastening member are respectively inserted into the fastening grooves in a clamping manner.

Abstract: Provided is a test apparatus including a fixing jig for vibration test of a battery pack. The fixing jig includes at least one upper block that is coupled to at least one coupler formed in the battery pack, a lower block placed below the at least one upper block, and a base plate having a board shaped and placed below the lower block.

Abstract: A RNA/DNA nanoparticle for delivering siRNA where a RNA transcript including at least one hairpin structure hybridizes DNA-cholesterol conjugate and folate-DNA conjugate including a complementary sequence to the RNA transcript, and a composition including the RNA/DNA nanoparticle is provided. More specifically, because various siRNA used for different applications can be contained in the RNA/DNA nanoparticle for delivering siRNA at a high loading efficiency, and has stability to the outer attacks such as nuclease degradation. The RNA/DNA nanoparticle siRNA can be prepared by self-assembly without using polycationic agent which is harmful agent for body. The folate targeting to various cancer cells can accumulate the nanoparticle selectively on target cancer cell after intravenous injection, and make excellent gene-silencing effect inside the cancer tissue, thereby being used as a good agent for treating cancers.

Abstract: Provided is an interconnection member including: (a) a main cable made of a flexible flat cable (FFC) including a plurality of copper wires; (b) a plurality of terminal parts branched from the main cable and electrically connected to at least one of the copper wires of the main cable, the plurality of terminal parts being connected to the bus bars to sense voltages of the battery cells; (c) a connecting part formed on one-side end of the main cable, and electrically and mechanically connected to the PCB; and (d) at least one temperature sensing part branched from the main cable, adjacent to the connecting part, while sharing at least one of the copper wires of the main cable.

Abstract: Provided is a test apparatus including a fixing jig for vibration test of a battery pack. The fixing jig includes at least one upper block that is coupled to at least one coupler formed in the battery pack, a lower block placed below the at least one upper block, and a base plate having a board shaped and placed below the lower block.

Abstract: A battery cell assembly in which a plurality of electrically connected battery cells are arranged and first and second outer cover members each having a plate-type structure surrounding an outer surface of the battery cell assembly and coupled to each other by a fastening member in a state in which corners corresponding to each other are in contact with each other. Here, each of the first and second outer cover members includes at least one fastening groove having a slit shape, and the fastening grooves of the first and second outer cover members are perforated at positions corresponding to each other of corners contacting each other, and the first and second outer cover members are coupled to each other in such a manner that both side ends, which face each other, of the fastening member are respectively inserted into the fastening grooves in a clamping manner.

Abstract: A RNA/DNA nanoparticle for delivering siRNA where a RNA transcript including at least one hairpin structure hybridizes DNA-cholesterol conjugate and folate-DNA conjugate including a complementary sequence to the RNA transcript, and a composition including the RNA/DNA nanoparticle is provided. More specifically, because various siRNA used for different applications can be contained in the RNA/DNA nanoparticle for delivering siRNA at a high loading efficiency, and has stability to the outer attacks such as nuclease degradation. The RNA/DNA nanoparticle siRNA can be prepared by self-assembly without using polycationic agent which is harmful agent for body. The folate targeting to various cancer cells can accumulate the nanoparticle selectively on target cancer cell after intravenous injection, and make excellent gene-silencing effect inside the cancer tissue, thereby being used as a good agent for treating cancers.

Abstract: The present invention relates to a recombinant protein for siRNA delivery, which allows the efficient intracellular and in vivo delivery of siRNA. More particularly, the present invention relates to a recombinant protein that allows a siRNA binding protein to be located in the interior cavity of a capsid protein of HBV (Hepatitis B virus), in which siRNAs of interest bind to the siRNA binding protein to be encapsulated within the capsid shell, thereby providing stability against the external attack such as nucleases and achieving the efficient intracellular and in vivo delivery of siRNA by its release into the cytosolic space after cell uptake.